arrhythmia

This Week in PNAS

In PNAS this week: sequencing approaches to characterize cisplatin-mediated DNA damage, somatic mosaicism in long-QT syndrome case, and more.

The firm will provide in-kind testing for 900 cases in the Sudden Death in the Young registry where the cause of death could not be determined by an autopsy.

This Week in PLOS

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

NEW YORK (GenomeWeb News) – By combining a meta-analysis with follow-up experiments in two model systems, an international team of researchers uncovered 14 new loci associated with heart rate and homed

By Uduak Grace Thomas
A new computer model of the human heart could help predict side effects of drugs used to treat abnormal heart rhythms, according to its developers.

The companies will study the potential role of galectin-3 in screening patients for cardiac-resynchronization therapy.

The partners are deciding whether to run the multiplex test on a microarray or a sequencing platform. Factors in the decision include the complexity of the test and the technical feasibility of multiplexed, targeted resequencing.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.